← Back to Search

3 Wishes Project for End-of-Life Care

N/A

Waitlist Available

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

<18 years old

Does not speak English or Spanish

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after patient's death (families will be surveyed 3 months after the date of death).

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to introduce the 3 Wishes Project (3WP) in safety-net hospitals to improve end-of-life care for patients in underserved communities. The project has shown positive effects on the

Who is the study for?

This trial is for patients at the end of their life in safety-net hospitals, which often serve diverse and disadvantaged populations. The goal is to improve the quality of end-of-life care by honoring final wishes.

What is being tested?

The '3 Wishes Project' (3WP) aims to enhance dignity in dying by implementing personalized gestures of compassion. This study tests if 3WP can positively impact end-of-life experiences in resource-limited hospitals.

What are the potential side effects?

Since this intervention involves non-medical acts of kindness rather than drugs or medical procedures, there are no traditional side effects. However, emotional impacts may vary among patients and families.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Select...

I do not speak English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after patient's death (families will be surveyed 3 months after the date of death).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after patient's death (families will be surveyed 3 months after the date of death).

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after patient's death (families will be surveyed 3 months after the date of death). for reporting.